Print（PDF/231KB） Aug. 04, 2026 Others

Sumitomo Pharma Contributes to Relief Efforts for the 2026 Kumamoto Earthquake

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) expresses its deepest condolences to the 2026 Kumamoto Earthquake that occurred in Kumamoto Prefecture on July 28, 2026 and sincerely wishes for the swift recovery and reconstruction of the affected communities.

Sumitomo Pharma announced today that the Company will make a donation of JPY 5 million through Kumamoto Prefecture to aid relief efforts for victims of the earthquake.